Infection and Drug Resistance
Volume 8, 2015 - Issue
Open access
130
Views
18
CrossRef citations to date
0
Altmetric
Review
Delamanid expanded access novel treatment of drug resistant tuberculosis
Roxana Rustomjee1 South African Medical Research Council, Cape Town, South AfricaCorrespondence[email protected]
& Alimuddin Zumla2 Division of Infection and Immunity, University College London, London, UK;3 NIHR Biomedical Research Centre, University College Hospitals NHS Foundation Trust, London, UK
Pages 359-366
|
Published online: 29 Oct 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.